Anne Wojcicki

CEOSeries: 23andMe's Anne Wojcicki on Scientific Breakthroughs and Public Trust | HBR IdeaCast 25 Jan 2023 --- Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR’s Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry. This episode originally aired on HBR IdeaCast on May 20, 2021. Listen to more HBR IdeaCast episodes here: https://www.youtube.com/playlist?list=PLzAU8TPKsJuaxff5Cp0P2DKE_tFyaWOOa You can also listen to this episode on HBR.org, and wherever you listen to podcasts: - HBR.org (transcript available here): https://hbr.org/podcast/2021/05/ceo-series-23andmes-anne-wojcicki-on-scientific-breakthroughs-and-public-trust - Apple Podcasts: https://podcasts.apple.com/us/podcast/ceo-series-23andmes-anne-wojcicki-on-scientific-breakthroughs/id152022135?i=1000522819828c - Spotify: https://open.spotify.com/episode/4sNOZtOWT8UaVuTzvBhrql?si=EBp4B9Y2QU-V22KoxdJNyQ - Stitcher: https://www.stitcher.com/show/hbr-ideacast/episode/ceo-series-23andmes-anne-wojcicki-on-scientific-breakthroughs-and-public-trust-84103562 - Google Podcasts: https://podcasts.google.com/feed/aHR0cDovL2ZlZWRzLmhhcnZhcmRidXNpbmVzcy5vcmcvaGFydmFyZGJ1c2luZXNzL2lkZWFjYXN0/episode/dGFnOmF1ZGlvLmhici5vcmcsMjAwNi0wNS0wODppZGVhY2FzdC4wNzk2?sa=X&ved=0CAIQuIEEahcKEwiokZDx-N38AhUAAAAAHQAAAAAQLA Series Description: A weekly podcast featuring the leading thinkers in business and management. About Harvard Business Review: Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, books, and digital content and tools published on HBR.org, Harvard Business Review aims to provide professionals around the world with rigorous insights and best practices to help lead themselves and their organizations more effectively and to make a positive impact. Learn more at www.hbr.org. Chapters: 00:00 – Intro 1:25 – A Customer-First Approach to Business Development 6:53 – Customer Data and Public Trust 12:27 – Takeaways from Anne’s Journey 17:16 – Audience Questions 19:06 – What’s Next for Genetic Research and Healthcare? 23:37 - Outro Follow Harvard Business Review: https://hbr.org/ https://www.linkedin.com/company/harv... https://www.facebook.com/HBR/ https://twitter.com/HarvardBiz https://www.instagram.com/harvard_bus... Sign up for Newsletters: https://hbr.org/email-newsletters #HarvardBusinessReview #business #management Copyright © 2022 Harvard Business School Publishing. All rights reserved. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 43 of The CEO Diary with Fexingo takes you inside the rollercoaster ride of Anne Wojcicki and 23andMe. Starting in 2006, Wojcicki set out to democratize genetic testing, selling $99 saliva kits directly to consumers. But in 2013, the FDA slammed the door, ordering the company to stop marketing health reports. Lucas and Luna break down how Wojcicki navigated the multi-year regulatory battle, kept the company alive through sheer grit and a pivot to ancestry data, and eventually won FDA approval for genetic health risk reports in 2017. They explore the hard choices: laying off half the staff, losing key partnerships, and the controversial decision to sell raw data to pharma. A masterclass in resilience and regulatory strategy for any founder facing government scrutiny. #AnneWojcicki #23andMe #DirectToConsumer #FDA #GeneticTesting #RegulatoryStrategy #Biotech #Startup #Resilience #ConsumerGenomics #HealthTech #Business #CEOInterview #Leadership #FexingoBusiness #BusinessPodcast #CornerOffice #FounderStory Keep every episode free: buymeacoffee.com/fexingo

Anne Wojcicki: La emprendedora que democratizó la genética con 23andMe En un mundo donde la ciencia parecía reservada a laboratorios lejanos y costosos, Anne Wojcicki decidió cambiar las reglas del juego. Cofundadora de 23andMe, ha sido pionera en acercar la genética al gran público, permitiendo que millones de personas descubran sus raíces, sus riesgos de salud y su conexión con la humanidad. S u enfoque audaz, su visión científica y su convicción en el empoderamiento del usuario la han convertido en una de las emprendedoras más influyentes del siglo XXI. ¿Quién es Anne Wojcicki? Anne Wojcicki es una bioemprendedora estadounidense nacida en 1973, conocida mundialmente por cofundar 23andMe, una de las primeras empresas en ofrecer pruebas genéticas directas al consumidor. Su visión de que cada persona pudiera conocer su información genética sin intermediarios revolucionó la biotecnología y provocó debates sobre privacidad, ética y medicina personalizada.

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her non-profit TTAM for $305 million, surpassing a prior winning bid from Regeneron. The deal, which excludes the company’s liabilities, may ease public concerns over genetic data transfers, given Wojcicki’s continued leadership. The acquisition still requires court approval, while lawsuits related to a 2023 data breach remain unresolved. The company’s shares have surged on recovery hopes. -Thinking of buying a Starlink? Use my link to support the show. -Get a United Chase Card and 10,000 miles, you are supporting GNC Travel with your signup! Subscribe to the Newsletter . Join the Chat @ GeekNews.Chat Email Todd or follow him on Facebook. Like and Follow Geek News Central’s Facebook Page . Download the Audio Show File New YouTube Channel – Beyond the Office Support my Show Sponsor: Best Godaddy Promo Codes Full Summary: In this episode titled “Anne Wojcicki regains control of 23andMe,” Todd Cochrane discusses the lead story about Annie Wojcicki, who successfully repurchased the genetic testing company 23andMe out of bankruptcy for $305 million through her nonprofit, ITAM. This acquisition enables Wojcicki to retain leadership while excluding company liabilities, although it requires court approval amid unresolved lawsuits stemming from a 2023 data breach. Cochrane expresses relief that the acquisition was not taken over by a firm potentially interested in exploiting customer genetic data, given that he has never submitted his DNA to any testing firms. He elaborates on past controversies surrounding 23andMe, including legal issues that previously barred Wojcicki from bidding on her company. Cochrane highlights that Wojcicki is backed by a Fortune 500 firm, which enhances confidence about the future of 23andMe. Following the main story, Cochrane welcomes listeners to episode 1827 and gives shoutouts to his sponsor, GoDaddy. He encourages listeners to support Geek News Central (GNC) and interact with the show through various platforms. He also mentions his personal experience with diabetes management technology, specifically blood sugar monitoring devices that he’s decided to try. Afterward, Cochrane dives into other tech news stories. He covers topics including the launch of Oakley smart glasses. This ISS leak has delayed the Axiom mission, the prediction that the next Galaxy Watch will monitor antioxidant levels, and the unveiling of a new affordable electric car from Kia. He also discusses various cybersecurity issues, such as Google’s ongoing antitrust scr

Anne Wojcicki, founder of 23andMe, has successfully repurchased the genetic testing firm out of bankruptcy through her non-profit TTAM for $305 million, surpassing a prior winning bid from Regeneron. The deal, which excludes the company’s liabilities, may ease public concerns over genetic data transfers, given Wojcicki’s continued leadership. The acquisition still requires court approval, while … Continue reading Anne Wojcicki Reclaims 23andMe in $305M Deal #1827 → The post Anne Wojcicki Reclaims 23andMe in $305M Deal #1827 appeared first on Geek News Central .

This Week in Startups is brought to you by… CLA - Get started with CLA's CPAs, consultants, and wealth advisors now at https://www.claconnect.com/tech House of Macadamias - Get a free month's supply of Macadamia Milk with any order at https://www.houseofmacadamias.com/twist by using code TWIST20! .Tech Domains - Apply to get your startup featured on This Week in Startups at https://www.startups.tech/jason Today’s show: 23andMe's Anne Wojcicki joins Jason for a deep dive on genome testing and healthcare. They cover the dramatic reduction in genome sequencing costs from billions to just $99 (3:15), the role of blood testing and sequencing in shaping 23andMe's health approach (27:02), the curious case of the venomous Gila monster (42:09), and much more! * Timestamps: (0:00) Anne Wojcicki of 23andMe joins Jason for an insightful discussion. (1:28) Exploring the impact of 23andMe and the trend of genome sequencing for proactive health management. (3:15) Tracing the dramatic reduction in genome sequencing costs from billions to just $99. (10:58) CLA - Get started with CLA's CPAs, consultants, and wealth advisors now at https://www.claconnect.com/tech (12:24) Discussing a pivotal moment in advancing our understanding of health and genetics. (18:41) Strategies for integrating new health initiatives in the U.S. and international healthcare systems. (22:26) House of Macadamias is the next big health trend! Get a free month's supply of Macadamia Milk with any order at https://www.houseofmacadamias.com/twist by using code TWIST20! (23:54) Addressing the need for a paradigm shift in healthcare policies and incentive structures. (27:02) The role of blood testing and exome sequencing in shaping 23andMe's comprehensive health approach. (30:45) Embracing a holistic perspective in personal health and wellness. (32:57) .Tech Domains has a new program called startups.tech, where you can get your startup featured on This Week in Startups. Go to http://www.startups.tech/jason to find out how! (34:02) Emphasizing the significance of regular blood tests for health monitoring. (41:55) A lesson in healthcare for everyone and the curious case of the venomous Gila monster. (48:59) Connecting the dots between modern healthcare, science, and technology: A real-life 'choose-your-own-adventure'. (52:39) Exploring the benefits of Lemonaid Health's acquisition by 23andMe. (58:32) Anne Wojcicki reflects on her 17-year journey in the field and shares her vision for the future of health and genetics. * Subscribe to This Week in Startups on Apple: https://rb.gy/v19fcp * Check out 23andMe: https://www.23andme.com * Follow Anne: X: https://twitter.com/annewoj23 LinkedIn: https://www.linkedin.com/in/annewojcicki Follow Jason: X: https://twitter.com/jason Instagram: https://www.instagram.com/jason LinkedIn: https://www.linkedin.com/in/jasoncalacanis * Thanks to our partners: (10:58) CLA - Get started with CLA's CPAs, consultants, and wealth advisors now at https://www.claconnect.com/tech (22:26) House of Macadamias is the next bi

Anne Wojcicki and her co-founders started 23andMe back in 2006 with a clear mission: to make genetic testing and its results, including findings about predisposition to disease, widely available to consumers. And, in exchange for a swab of spit and a fee, 23andMe provided its customers with unprecedented insight into their own genetic makeup. Now, Wojcicki and her company are at the forefront of a broader movement to expand personalized care and drug options in healthcare. In today’s episode, Anne talks about the challenges in understanding the code of life, the benefits of DNA testing, concerns over privacy in the healthcare industry, and the future of medicine and new drug discovery. Anne Wojcicki is a biologist, entrepreneur, and the co-founder and CEO of the personal genomics company 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup. In this episode, Hala and Anne will discuss: - Anne's disillusionment with the U.S. healthcare system - The power of the human genome - The challenges of direct-to-consumer DNA tests - The real reason 23andMe was so controversial - Handling FDA concerns - Challenges of achieving transparency and privacy - How people’s lives have been changed by taking the 23andMe test - Integrating genetics into patient care - How large datasets are helping solve health mysteries - Building a direct-to-consumer healthcare movement - Combining genetics with drug discovery research - Expanding 23andMe’s non-European databases - How AI will change the medical landscape - And other topics… Anne Wojcicki is a biologist, entrepreneur, and the co-founder and CEO of the personal genomics company 23andMe. She has been on Forbes’ list of the World's 100 Most Powerful Women and has been named “The Most Daring CEO” by Fast Company. Her company 23andMe provides genetic testing for individuals curious about their ancestry and genetic makeup, but it is doing a lot more than that, including helping to revolutionize how we think about drug discovery and the genetics of health. Resources Mentioned: Anne’s Website: https://blog.23andme.com/tag/anne-wojcicki Anne’s LinkedIn: https://www.linkedin.com/in/annewojcicki/ Anne’s Twitter: https://twitter.com/annewoj23?lang=en Anne’s Instagram: https://www.instagram.com/annewoj23/?hl=en Where you can order a 23andMe Health and Ancestry Kit: https://www.23andme.com/dna-health-ancestry/ LinkedIn Secrets Masterclass, Have Job Security For Life: Use code ‘podcast’ for 30% off at yapmedia.io/course . Key YAP Links Reviews - ratethispodcast.com/yap Youtube - youtube.com/c/YoungandProfiting LinkedIn - linkedin.com/in/htaha/ Instagram - instagram.com/yapwithhala/ Social + Podcast Services: yapmedia.com Transcripts - <a href="http://youngandprofiting.com/ep

Anne Wojcicki is an innovative biologist and the co-founder and CEO of personal genomics company 23andMe. In 2006, Anne saw a need for creating a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. The result was 23andMe, which provides genetic testing for individuals curious about their ancestry and genetic makeup. It was named "Invention of the Year" by Time Magazine in 2008, and in 2013, The Fast Company named Anne “The Most Daring CEO.” We spoke with Anne all about her upbringing and the story of how 23andMe came to be. * The Founder Hour is brought to you by Outer. Outer makes the world’s most beautiful, comfortable, innovative, and high-quality outdoor furniture - ALL from sustainable materials - and is the ONLY outdoor furniture with a patented built-in cover to make protecting it effortless. From teak chairs to fire pit tables, everything Outer makes has the look and feel of what you’d expect at a 5-star resort, for less than you’d pay at a big box store for something that won’t last. For a limited time, get 10% off and FREE shipping at www.liveouter.com/thefounderhour . Terms and conditions apply. * This episode is brought to you by “More Than Profit.” If you enjoy The Founder Hour, we think you’ll enjoy this podcast too. It celebrates entrepreneurs, investors, and leaders that are living and working with purpose. The host, Bryce Butler, sits down with his guests and shares personal stories about what it’s like to succeed…and even fail. But more than that, what motivates them beyond just profit to press forward in their work and as a leader. Check out “More Than Profit” wherever you get your podcasts or at www.morethanprofit.fm . *** Follow The Founder Hour on: Instagram | www.instagram.com/thefounderhour Twitter/X | www.x.com/thefounderhour LinkedIn | www.linkedin.com/company/thefounderhour YouTube | www.youtube.com/@thefounderhour

Imagine waking up and knowing exactly what foods you need, how much to move, what to drink, and the exact time to go to sleep to feel your best every day. It might seem far-fetched, but the world of personalized wellness is emerging, and it's changing the way we understand the human body and what is possible. In this episode of First In Line, we're joined by Anne Wojciki, the CEO of 23andMe, and Dr. Molly Maloof, a biohacker focused on human optimization. You'll learn about the things you can do today to feel, look, and perform better than ever — and the innovations of tomorrow that are helping you optimize every aspect of your health. — Where to Find Anne Wojcicki: • Twitter: https://twitter.com/annewoj23 • Instagram: https://www.instagram.com/annewoj23 Where to Dr. Molly Maloof: • Twitter: https://twitter.com/mollymaloofmd • Instagram: https://www.instagram.com/drmolly.co • Website: https://drmolly.co/ — Thank you to our sponsor for making this episode possible: This episode is brought to you by LMNT . LMNT is a delicious electrolyte drink mix with all of the things you need and none of the junk. It contains a science-backed electrolyte ratio: 1000 mg sodium, 200 mg potassium, 60 mg magnesium. LMNT can help prevent and eliminate headaches, muscle cramps, fatigue, sleeplessness, and other common symptoms of electrolyte deficiency. It tastes amazing and is great after a workout or one too many drinks :) Right now LMNT is offering our listeners a free sample pack with any order. That’s 8 single serving packets FREE with any LMNT order. Get yours at DrinkLMNT.com/BRIT . And it’s so good they have a no questions asked refund policy but you won’t need it. Production and marketing by https://penname.co . — In this episode, we cover: (04:40) Why Anne created 23andMe to empower consumers (09:40) The importance of having data about your genetics (14:39) What information can you learn from genetic testing (15:50) How insurance companies operate through cost analysis and do not optimize for patient experience (16:35) What is Factor V Leiden and how can learning if you have this mutation save your life (18:53) Why nutrition studies are hard to do—and which information is actually helpful and actionable (21:06) How Dr. Molly finds the optimal diet for each patient (23:07) Which genes influence how nutrients are metabolized (24:55) Where to go to have your 23andMe data interpreted (27:07) The controversy of the MTHFR gene (29:14) What is the warrior gene (30:05) Why some studies are not relevant to all groups of people (31:00) What genetic information can conclusively show and what is it not likely to show (33:31) What your genetics show about sleep and why if you’re at risk for diabetes, you should go to bed before 10:00 PM (35:20) Why you should learn how you metabolize caffeine (38:00) Tools and tips from Anne (44:46) Anne’s thoughts on what’s next with using data, health, and genetic interplay — Referenced: • 23andMe: https://www.23andme.com/ • Factor V Leiden: https://my.clevela

Three years after the first human genome was sequenced, Anne Wojcicki cofounded 23andMe. After a decade on Wall Street investing in healthcare, Anne started a new career chapter as a founder working to empower people with direct access to genetic information. Fast-forward and 23andMe has become the only personal genetic test with FDA authorization to deliver health information directly to consumers. To date, over 12 million people have taken a 23andMe DNA test kit. Anne shares why she adopted a low-margin and high-volume business strategy, why she believes personalized medicine is the future, and how figuring out time management was one of her biggest hurdles.

Anne Wojcicki started 23andMe in 2006 to empower consumers with access to their own genetic information. In this episode, she shares the highs and lows of this journey including getting an FDA warning letter, going public, and genotyping over 12 million customers. Plus, she shares why she thinks our healthcare system is a communist system, their role in the discussion of race, and how genetic relative surprises are remarkably common. Follow Anne Wojcicki on Twitter. Follow host Halle Tecco on on Twitter. Visit The Heart of Healthcare website for episode recaps. Visit offscrip.com/shows for more podcasts. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info .

"By having a large amount of data, we are starting to understand, what does the human genome mean?" In this View From The Top, Alexandra Eitel, MBA '22 sits down with Anne Wojcicki, Co-founder and CEO of 23andMe to discuss breaking down inequality through genetics, statistical power, building trust with transparency , and how digital healthcare is being revolutionized. "I think there should be transparency and there should be choice," says Wojcicki. 👉Become a Paid Subscriber: anchor.fm/ge 👉Get my free book: https://fierce-composer-3082.ck.page/f7262cf1ed 👉SUBSCRIBE/ Leave a Review TO THE PODCAST https://anchor.fm/getu-chandler